Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T09:39:56.055Z Has data issue: false hasContentIssue false

Maintenance pharmacotherapy for recurrent major depressive disorder: 5-year follow-up study

Published online by Cambridge University Press:  02 January 2018

Irina A. K. Holma
Affiliation:
Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki
K. Mikael Holma
Affiliation:
Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki
Tarja K. Melartin
Affiliation:
Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, and Department of Psychiatry, HUCH, Peijas Hospital, Health Care District of Helsinki and Uusimaa, Vantaa
Erkki T. Isometsä*
Affiliation:
Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, and Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland
*
Erkki T. Isometsä, MD, PhD, Institute of Clinical Medicine, Department of Psychiatry, P.O. Box 22 (Välskärinkatu 12 A), 00014 University of Helsinki, Finland. Email: erkki.isometsa@hus.fi
Rights & Permissions [Opens in a new window]

Summary

Practice guidelines endorse maintenance antidepressant treatment for recurrent major depressive disorder. In the Vantaa Depression Study, we followed 218 psychiatric patients with major depressive disorder for up to 5 years with a life-chart. Of these patients, 86 (39.4%) had more than three lifetime episodes and an indication for maintenance pharmacotherapy. However, of these, only 57% received treatment and only for 16% of the time indicated. Good adherence to pharmacotherapy in the acute phase independently predicted maintenance treatment. The tertiary preventive impact of maintenance treatment may remain limited, as many patients with major depressive disorder either do not receive it, or receive it for too short a period.

Information

Type
Short Reports
Copyright
Copyright © Royal College of Psychiatrists, 2008 
Supplementary material: PDF

Holma et al. supplementary material

Supplementary Table S1

Download Holma et al. supplementary material(PDF)
PDF 35.5 KB
Supplementary material: File

Holma et al. supplementary material

Supplementary Material

Download Holma et al. supplementary material(File)
File 511 Bytes

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.